⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17022282 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL10012314 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL329461 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL3004 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL15586623 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL329394 | 0.97 | TSHR (0.55) | — | |
| SCHEMBL2024638 | 0.97 | TSHR (0.55) | — | |
| Hydrochloric Acid SCHEMBL11523265 | 0.94 | TSHR (0.52) | — | |
| SCHEMBL11696325 | 0.94 | TSHR (0.52) | — | |
| SCHEMBL7097318 | 0.94 | TSHR (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 565 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497354-B2 | Efficient conversion of methane to methanesulfonic acid via trifluoroacetylsulfuric acid | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-12-16 | — | — | US | claimed |
| CN-113646941-B | Electrolyte solution for lithium secondary battery and lithium secondary battery comprising same | 株式会社LG新能源 | 2024-07-02 | — | — | CN | claimed |
| CN-117050013-A | Mono (acid) salts of 6-aminoisoquinolines and use thereof | 爱瑞制药公司 | 2023-11-14 | — | — | CN | claimed |
| US-20230242477-A1 | EFFICIENT CONVERSION OF METHANE TO METHANESULFONIC ACID VIA TRIFLUOROACETYLSULFURIC ACID | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2023-08-03 | — | — | US | claimed |
| CN-115720579-A | Antibacterial and antifungal pleuromutilin conjugates | 赛丹思科大学 | 2023-02-28 | — | — | CN | claimed |
| CN-113646941-A | Electrolyte solution for lithium secondary battery and lithium secondary battery including the same | 株式会社LG新能源 | 2021-11-12 | — | — | CN | claimed |
| EP-3773580-A1 | MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF | Aerie Pharmaceuticals, Inc. (US) | 2021-02-17 | — | — | EP | claimed |
| US-20200390100-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | BAYER AG (DE) | 2020-12-17 | — | — | US | claimed |
| CN-111936139-A | Mono (acid) salts of 6-aminoisoquinoline and uses thereof | 爱瑞制药公司 | 2020-11-13 | — | — | CN | claimed |
| EP-3728214-A1 | SUBSTITUTED N-HETEROCYCLYL- AND N-HETEROARYL-TETRAHYDROPYRIMIDINONES AND THE SALTS THEREOF, AND THE USE OF SAME AS HERBICIDAL ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2020-10-28 | — | — | EP | claimed |
| EP-1763303-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | Bayer CropScience Aktiengesellschaft (DE) | 2007-03-21 | — | — | EP | claimed |
| EP-1163250-B1 | IMPROVED SYNTHESIS OF ¬2.2.1|BICYCLO NUCLEOSIDES | EXIQON AS (DK) | 2006-07-12 | — | — | EP | claimed |
| WO-2006066109-A2 | HYDROXYSTEROID DEHYDROGENASE INHIBITORS | TAKEDA SAN DIEGO, INC. (US) | 2006-06-22 | — | — | WO | claimed |
| WO-2006000333-A1 | SUBSTITUTED PYRIDAZINE CARBOXAMIDES AND DERIVATIVES THEREOF | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2006-01-05 | — | — | WO | claimed |
| EP-1501848-A1 | SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES | Santaris Pharma A/S (DK) | 2005-02-02 | — | — | EP | claimed |
| US-20040014959-A1 | Synthesis of locked nucleic acid derivatives | SANTARIS PHARMA A/S (DK) | 2004-01-22 | — | — | US | claimed |
| WO-2003095467-A1 | SYNTHESIS OF LOCKED NUCLEIC ACID DERIVATIVES | SANTARIS PHARMA A/S (DK) | 2003-11-20 | — | — | WO | claimed |
| US-6225347-B1 | FOR LOWERING BLOOD PRESSURE, INHIBITING PLATELET AGGREGATION, FOR LUTEOLYTIC EFFECT, HEALING ULCER, INHIBITING GASTRIC ACID SECRETION, AS CYTOPROTECTIVE AGENT | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-05-01 | — | — | US | claimed |
| US-5891910-A | 9-halogen-(Z) prostaglandin derivatives, process for their production and their use as pharmaceutical agents | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-04-06 | — | — | US | claimed |
| US-4196204-A | ANTIANDROGENS, ACNE, SEBORRHEA | SCHERING AKTIENGESELLSCHAFT (DE) | 1980-04-01 | — | — | US | claimed |